Skip to main content

Olema Oncology, Inc 8-K, filed Nov 12, 2026

Olema Oncology, Inc. (OLMA)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 8-K

Olema Oncology, Inc filed this 8-K on November 12, 2026.

Olema Oncology, Inc. changed its name from Olema Pharmaceuticals, Inc. effective November 12, 2026. It also relocated its principal executive offices to 365 Oyster Point Blvd., Suite 400, South San Francisco, California 94080. AI summary

Items reported

  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 7.01: Regulation FD disclosure
  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits